Regarding your questions about ETFs with significant exposure to the biotech industry and the sector classification for biotechnology:
Several ETFs offer substantial investment in the biotechnology sector, providing diversified exposure to companies engaged in the research, development, and manufacturing of healthcare products. Among the largest and most well-known are the iShares Biotechnology ETF (IBB) and the SPDR S&P Biotech ETF (XBI). The iShares Biotechnology ETF (IBB) seeks to track the investment results of an index composed of U.S.-listed biotechnology and pharmaceutical companies. The SPDR S&P Biotech ETF (XBI) aims to replicate the performance of the S&P Biotechnology Select Industry Index, which focuses on the biotechnology sub-industry. These ETFs typically hold a broad range of biotech companies, from large-cap established firms to smaller, more volatile clinical-stage biotechs.
As for industry classification, biotechnology is generally categorized within the Healthcare Sector. More specifically, under standard industry classification systems like the Global Industry Classification Standard (GICS), biotechnology falls under the Pharmaceuticals, Biotechnology & Life Sciences Industry Group, and then specifically into the Biotechnology Sub-Industry. This classification helps investors and analysts categorize companies with similar business activities and market dynamics.
